These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies. Rosas CT; Paessler S; Ni H; Osterrieder N Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789 [TBL] [Abstract][Full Text] [Related]
7. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83. Phillpotts RJ Vaccine; 1999 May; 17(19):2429-35. PubMed ID: 10392625 [TBL] [Abstract][Full Text] [Related]
8. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus. Phillpotts RJ; Jones LD; Howard SC Vaccine; 2002 Feb; 20(11-12):1497-504. PubMed ID: 11858855 [TBL] [Abstract][Full Text] [Related]
10. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge. Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A Front Immunol; 2020; 11():598847. PubMed ID: 33542715 [TBL] [Abstract][Full Text] [Related]